In humans, Mendelian defects in MyD88 and CARD9 signaling do not lead to the spontaneous development of aspergillosis, unlike individuals with Mendelian defects in NADPH oxidase activity (i.e. chronic granulomatous disease). Here, FMO5 is linked to aspergillosis.